Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 13093

Страница 1 из 1310

A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
Kiselev V.I., Ashrafyan L.A., Muyzhnek E.L., Gerfanova E.V., Antonova I.B., Aleshikova O.I., Sarkar F.H.
-year maintenance therapy with indole-3-carbinol (I3C) as well as I3C and epigallocatechin-3-gallate (EGCG
Combination antihypertension therapy: The “underresearched” combinations
Kotovskaya Y.V., Runikhina N.K., Ostapenko V.S.
Decrease of blood pressure (BP) and its maintenance on target level is the main factor
Modern aspects of preventive maintenance of inflammatory complications at patients with urolithiasis after distant lithotripsy
Fedchenkov V.V., Hodenkov S.S., Kruglov B.A.
-laser therapy and litholitolis therapy for preventive maintenance of inflammatory complications at patients
THE INFLUENCE OF LIKOPID IMMUNOMODULATOR ON THE MAINTENANCE OF THE TUMOR NECROSIS FACTOR-ALFA IN BLOOD SERUM IN THE PATIENTS WITH THE PSORIASIS
GORSKIY V.S., TISCHENKO A.L., RUDNEVA N.S.
of this preparation in complex therapy of a psoriasis is pathogenetically reasonable.
Safety and effectiveness of continuous denosumab for unresectable or advanced giant cell tumor
Tararykova A.A., Fedenko A.A., Musaev E.R., Valiev A.K., Borzov K.A., Sushentсov E.A., Sofronov D.I., Sokolovskii A.V., Dzampaev K.A.
effect patient then received maintenance therapy: once in three months injection. All patients received
COMBINATION ANTIHYPERTENSION THERAPY: THE "UNDERRESEARCHED" COMBINATIONS
Kotovskaya Y.V., Runikhina N.K., Ostapenko V.S.
Decrease of blood pressure (BP) and its maintenance on target level is the main factor
Problems and prospects of gene therapy against HIV
Schneider A., Wagner A., Davydova E.E., Smirnov A.S., Glazkov I.N., Shegai M.M., Glazkova D.V.
of the principal problems of gene therapy is the maintenance in modified cells of the required level of anti
Current immunopathological therapy of psoriasis
BATKAYEV E.A., CHISTYAKOVA I.A.
.m. during 15 days, followed by maintenance therapy with nasal Thymodepressin 0.5-0.2 mL during 2-4 weeks
Ингибиторы иммунных контрольных точек в терапии рака мочевого пузыря: опыт применения авелумаба
Грицкевич А.А., Байтман Т.П., Мишугин С.В., Попов А.Ю., Ягудаев Д.М., Фалалеева Л.А., Русаков И.Г.
inhibitors. To date, platinum-containing chemotherapy followed by maintenance therapy with avelumab
Groups of risk and quantum preventive maintenance complications at diseases of urinogenital system
Avdoshin W.P., Belopolsky A.A., Belopolsky CH.A., Hertsen A.W., Kuznetsov V.I., Sidorova I.S.
Groups of risk and quantum preventive maintenance complications at diseases of urinogenital system

Страница 1 из 1310

Фасеты

Новости проекта

Новости

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core